Exhibition Review | The 4th BIONNOVA Western Innovation Forum 2025 concluded successfully in Chengdu. Looking forward to meeting again and creating a new chapter together!
The 4th BIONNOVA Western Innovation Forum was successfully concluded at the Chengdu Intangible Cultural Heritage Park Tivoli Hotel on July 22-23, 2025. This grand event brought together top executives from leading pharmaceutical companies, innovative technology developers, authoritative industry experts and industrial representatives to focus on the cutting-edge technologies and industrial practices in biomedicine, and jointly explore new opportunities and breakthrough paths in the face of changes.
This BIONNOVA Western Innovation Forum featured 16 parallel sessions, covering over 140 top industry experts discussing innovative fields such as antibody drugs, ADC, cell and gene therapy, small molecule innovative drugs, nucleic acid drugs, nuclear drugs, and polypeptide drugs; major disease areas including anti-tumor, autoimmune, metabolism, and CNS; as well as hot topics like registration applications, preclinical studies, clinical development, analytical quality control, and CMC process practice case analyses. Together, they explored the latest industry trends, shared forward-looking insights, and worked towards the future.
Moreover, over 120 outstanding CRO/CDMO, AI drug development companies, biotech product providers, raw material/auxiliary suppliers, reagents/consumables manufacturers, instrument/equipment vendors, research institutions, and related service providers from both China and abroad will showcase their innovative biotech products and services at BIONNOVA. Together with representatives from leading domestic enterprises, they will engage in discussions, collaborate on innovation, map out future development strategies, and jointly achieve remarkable success.
The sales and technical departments of Cellgene Bioscience attended this conference and presented and shared a number of core research achievements. This exhibition showcased multiple product series including the Host Cell Protein Residue Detection kit, Host Cell DNA Residue Detection kit, Recombinant Protein, as well as single and multi-antigen detection test strips. The technical department colleague also provided professional technical services. With cutting-edge products and high-quality services, a large number of customers came to the exhibition booth for professional exchanges, and the on-site interaction was very lively. The professional and detailed explanations not only gained widespread attention but also received high recognition from industry colleagues, fully demonstrating Cellgene Bioscience's technology and strength in the field of biopharmaceuticals.
We sincerely thank all the friends who have come to our exhibition! Your presence is our support and encouragement, and it is a powerful driving force for us to keep moving forward. Your trust and recognition are our honor. The core development goal of Cellgene Bioscience has always been to deeply study the needs of pharmaceutical enterprises and strive to provide comprehensive technical solutions. We will carry this precious belief and motivate Cellgene Bioscience to continuously improve and break through, striving to do better and make you more satisfied. We hope that in future exhibitions, we will be able to meet you again and jointly write a new chapter in the industry, witnessing more growth and breakthroughs!
